These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26094122)

  • 1. A call for policy guidance on psychometric testing in doping control in sport.
    Petróczi A; Backhouse SH; Barkoukis V; Brand R; Elbe AM; Lazuras L; Lucidi F
    Int J Drug Policy; 2015 Nov; 26(11):1130-9. PubMed ID: 26094122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can We Better Integrate the Role of Anti-Doping in Sports and Society? A Psychological Approach to Contemporary Value-Based Prevention.
    Petróczi A; Norman P; Brueckner S
    Med Sport Sci; 2017; 62():160-176. PubMed ID: 28571017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological and social correlates of doping attitudes among Italian athletes.
    Zucchetti G; Candela F; Villosio C
    Int J Drug Policy; 2015 Feb; 26(2):162-8. PubMed ID: 25168080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes and doping: a structural equation analysis of the relationship between athletes' attitudes, sport orientation and doping behaviour.
    Petróczi A
    Subst Abuse Treat Prev Policy; 2007 Nov; 2():34. PubMed ID: 17996097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J; Zabala M
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illegal performance enhancing drugs and doping in sport: a picture-based brief implicit association test for measuring athletes' attitudes.
    Brand R; Heck P; Ziegler M
    Subst Abuse Treat Prev Policy; 2014 Jan; 9():7. PubMed ID: 24479865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-doping policy development process in the sports world (1968~1999): focusing on IOC activities and passive response from Korea].
    Hwang ER; Kim TY
    Uisahak; 2014 Aug; 23(2):269-318. PubMed ID: 25223222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-admitted behavior and perceived use of performance-enhancing vs psychoactive drugs among competitive athletes.
    Uvacsek M; Nepusz T; Naughton DP; Mazanov J; Ránky MZ; Petróczi A
    Scand J Med Sci Sports; 2011 Apr; 21(2):224-34. PubMed ID: 19903314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sport, Society, and Anti-Doping Policy: An Ethical Overview.
    Bloodworth AJ; McNamee M
    Med Sport Sci; 2017; 62():177-185. PubMed ID: 28571026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug misuse in sport: a New Zealand perspective.
    Curtis A; Gerrard D; Burt P; Osborne H
    N Z Med J; 2015 Dec; 128(1426):62-8. PubMed ID: 26913908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting elite Scottish athletes' attitudes towards doping: examining the contribution of achievement goals and motivational climate.
    Allen J; Taylor J; Dimeo P; Dixon S; Robinson L
    J Sports Sci; 2015; 33(9):899-906. PubMed ID: 25537139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Clean athlete status' cannot be certified: Calling for caution, evidence and transparency in 'alternative' anti-doping systems.
    Petróczi A; Backhouse SH; Boardley ID; Saugy M; Pitsiladis Y; Viret M; Ioannidis G; Ohl F; Loland S; McNamee M
    Int J Drug Policy; 2021 Jul; 93():103030. PubMed ID: 33250439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential analysis of the doping behaviour templates in three types of sports.
    Rodek J; Idrizović K; Zenić N; Perasović B; Kondric M
    Coll Antropol; 2013 May; 37 Suppl 2():211-7. PubMed ID: 23914509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.